Page 14 - Recursion Pharmaceuticals News Today

The widely followed growth stock investor is adding to some of her holdings this week.

The widely followed growth stock investor is adding to some of her holdings this week.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) was up 8% on Monday . The stock traded as high as $10.55 and last traded at $10.40. Approximately 868,527 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 7,476,085 shares. The stock had previously closed at $9.63. Analyst Upgrades […]

TipRanks’ analyst ranking service pinpoints Wall Street’s best-performing stocks, including Amazon and Nvidia.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CFO Michael Secora sold 25,000 shares of the business’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $10.45, for a total transaction of $261,250.00. Following the sale, the chief financial officer now directly owns 968,514 shares of the […]

The AI evolution in tech: Pioneering smarter decisions, from surgery to security - SiliconANGLE

These companies are still in the early innings of their growth potential.

These companies could stand out thanks to game-changing technology.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) Director Dean Y. Li sold 29,000 shares of Recursion Pharmaceuticals stock in a transaction that occurred on Tuesday, January 9th. The shares were sold at an average price of $13.66, for a total transaction of $396,140.00. Following the completion of the transaction, the director now owns 421,000 […]